Literature DB >> 7614939

Workshop on perinatal exposure to dioxin-like compounds. IV. Neurobehavioral effects.

M S Golub1, S W Jacobson.   

Abstract

Nine participants outlined findings in the area of neurobehavioral effects of dioxin-like compounds and presented plans for new studies. Neurobehavioral effects are among the most sensitive and well studied toxicity end points for this class of compounds. A focus of the workshop was presentation of designs for major new studies in human populations outside the United States that are intended to extend and clarify the results of two previous large-scale studies in populations in Michigan and North Carolina. Improved methods for exposure assessment and more focused approaches to understanding specific neurobehavioral deficits were highlighted. Animal studies and in vitro mechanistic studies are emphasizing the importance of alterations in neurotransmitter systems and thyroid function that may underlie behavioral dysfunction. There is continuing improvement in analytical and study design methods to identify the most active congeners of PCB mixtures in the environment. These diverse studies will contribute to effective response of public health and regulatory groups to this continuing problem.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614939      PMCID: PMC1518853          DOI: 10.1289/ehp.95103s2151

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  25 in total

1.  PCBs, DDE, and child development at 18 and 24 months.

Authors:  W J Rogan; B C Gladen
Journal:  Ann Epidemiol       Date:  1991-08       Impact factor: 3.797

2.  Sustained attention in children at risk for schizophrenia: findings with two visual continuous performance tests in a new sample.

Authors:  J Rutschmann; B Cornblatt; L Erlenmeyer-Kimling
Journal:  J Abnorm Child Psychol       Date:  1986-09

3.  Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects on growth, morbidity, and duration of lactation.

Authors:  W J Rogan; B C Gladen; J D McKinney; N Carreras; P Hardy; J Thullen; J Tingelstad; M Tully
Journal:  Am J Public Health       Date:  1987-10       Impact factor: 9.308

4.  Prenatal exposure to polychlorinated biphenyls: effects on birth size and gestational age.

Authors:  G G Fein; J L Jacobson; S W Jacobson; P M Schwartz; J K Dowler
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

5.  Infant search and object permanence: a meta-analysis of the A-not-B error.

Authors:  H M Wellman; D Cross; K Bartsch
Journal:  Monogr Soc Res Child Dev       Date:  1987

6.  Developmental equations reflect brain dysfunctions.

Authors:  H Ahn; L Prichep; E R John; H Baird; M Trepetin; H Kaye
Journal:  Science       Date:  1980-12-12       Impact factor: 47.728

Review 7.  Selecting measures of emotional and behavioral disorders of childhood for use in general populations.

Authors:  M H Boyle; S C Jones
Journal:  J Child Psychol Psychiatry       Date:  1985-01       Impact factor: 8.982

8.  The effect of intrauterine PCB exposure on visual recognition memory.

Authors:  S W Jacobson; G G Fein; J L Jacobson; P M Schwartz; J K Dowler
Journal:  Child Dev       Date:  1985-08

9.  Effects of perinatal exposure to specific PCB congeners on thyroid hormone concentrations and thyroid histology in the rat.

Authors:  D K Ness; S L Schantz; J Moshtaghian; L G Hansen
Journal:  Toxicol Lett       Date:  1993-06       Impact factor: 4.372

10.  Selective screening device for the early detection of normal or delayed cognitive development in infants at risk for later mental retardation.

Authors:  J F Fagan; L T Singer; J E Montie; P A Shepherd
Journal:  Pediatrics       Date:  1986-12       Impact factor: 7.124

View more
  1 in total

Review 1.  Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review.

Authors:  N Ribas-Fitó; M Sala; M Kogevinas; J Sunyer
Journal:  J Epidemiol Community Health       Date:  2001-08       Impact factor: 3.710

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.